secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001628280-24-022896
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks receives NYSE delisting notice for stock price below $1 for 30 trading days
--------------------------------------------------------------------------------

- NYSE notified Ginkgo on May 7, 2024 that average closing price of Class A common stock was below $1.00 over 30 consecutive trading days.
- No immediate delisting; six-month cure period to regain compliance by closing at $1.00 or above on last trading day of any calendar month.
- Stock continues trading on NYSE under symbol 'DNA' with '.BC' designation indicating non-compliance.
- Company intends to regain compliance and is evaluating all available options; business operations unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/0001628280-24-022896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024022896/dna-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-022896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer